Beta-adrenoblockers in clinical practice: is there any difference?
Modern views on various β-adrenoblockers (BB) place in clinical practice are presented. BB class is a clinically heterogeneous group. Recent criticism of BB should not disorient practitioners, who must understand which BB are mentioned. Some BB, mostly non-selective, demonstrate adverse effects and...
Saved in:
| Main Authors: | D. V. Nebieridze, A. Meliya, G. R. Kulieva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01) -
Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?
by: Yu. M. Lopatin
Published: (2009-12-01) -
Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01) -
RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)